Myworkout Medical
Software as Medical Device
From world-leading exercise science to regulated software care. Myworkout Medical is being developed to make clinically studied cardiovascular training scalable for essential hypertension. The product is under development and is not yet CE-marked, FDA-cleared or available for clinical use.
Partners
Myworkout GO app
A digital revolution in medicine, built on world-leading research
Myworkout Medical is being developed as software as a medical device to turn clinically studied exercise into scalable, measurable care delivery.
Regulatory status: Myworkout Medical is currently under development, not yet CE-marked or FDA-cleared, and not available for clinical use. The first planned indication is essential hypertension.
The technology is built on 30 years of research into exercise as medicine from NTNU's Faculty of Medicine, developed in-house by Myworkout with clinical and R&D partners since 2013.
Our ambition is to give clinicians a practical way to prescribe, support and follow structured exercise treatment with clear progress visibility.
Exercise therapy is just as effective as medical treatment in selected cases and, in special situations, more effective or adds to its effect.
B.K. Pedersen and B. Saltin, Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases.
Why this matters now
Healthcare systems face rising inactivity-related disease and limited capacity. They need scalable, evidence-grounded interventions that can be delivered without adding physical infrastructure.
Exercise as medicine
Published clinical research shows that specific exercise protocols can deliver clinically meaningful improvements across several chronic disease areas.
Digital treatment
Myworkout Medical is being designed to help clinicians prescribe, monitor and document structured exercise pathways at scale.
Sustainable medicine
In selected clinical contexts, structured exercise can complement conventional treatment and improve important outcomes with low distribution overhead.
Specific exercise
Our approach starts from more than 30 years of protocol-driven research in cardiorespiratory fitness and disease-related outcomes.
Low cost
Software delivery creates a potentially scalable model with low marginal distribution cost for healthcare systems.
Evidence-based digital treatment candidate
The underlying medical rationale is supported by peer-reviewed clinical research. The software product itself is under development.
Diagnosis-specific roadmap
Hypertension is the first planned indication. Beyond this, we see a broader pipeline of possible diagnosis-specific applications. Each future indication requires separate evidence review, risk assessment and regulatory clearance or approval before marketing.
- Phase 1
Hypertension.
- Phase 2
COPD, MS, Parkinson and Long Covid.
- Phase 3
Type 2 Diabetes.
- Phase 4
Additional indications may be explored after separate assessment.
Regulatory strategy
Myworkout Medical is being developed under a quality and regulatory framework for software as a medical device, including safety, usability and risk management processes.
- QMS being developed in alignment with ISO 13485:2016
- ISO 14971:2019 Risk Management
- IEC 62366-1:2015 Usability Engineering
Independent quality assessment of earlier Myworkout technology
In 2022, earlier Myworkout technology and documentation were assessed by Norwegian health authorities in areas including usability, medical basis, safety and data security, receiving an A rating. The company's strong focus on quality has enabled easier adoption to meet stricter regulatory requirements while working on Myworkout Medical.
Patient stories
Patents
Testimonial from a living legend
The patentable parts of the technology are not publicly disclosed. The product, technology and documentation have been developed in-house, with ownership and rights retained.
In 2016, Atari founder and former Steve Jobs mentor Nolan Bushnell tested Myworkout GO to reduce his biological age. His description of the experience became the origin of our slogan: More Life.
Financial opportunities
Myworkout Medical combines a clinically grounded methodology, proprietary software and a regulated SaMD execution path. We are open to partnerships that support regulatory execution, clinical deployment and international commercialization, starting with hypertension.
Contact us
We want to connect with clinics, hospitals and potential investors who find this solution interesting.